Article info
PDFCancer genetics
Short report
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer
- Correspondence to Dr Heli Nevanlinna, Helsinki University Central Hospital, Department of Obstetrics and Gynecology, Biomedicum Helsinki, PO Box 700, FIN-00029 HUS, Finland; heli.nevanlinna{at}hus.fi
Citation
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer
Publication history
- Received February 24, 2012
- Revised April 27, 2012
- Accepted May 2, 2012
- First published May 31, 2012.
Online issue publication
July 11, 2012
Article Versions
- Previous version (31 May 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.